September the 25th 2019 - (8 AM PDT | 11 AM EDT | 4 PM BST | 5 PM CEST), History of Digital PCR: (r)evolution in genetic testing & analysis by Dr. Wim Trypsteen (University of Ghent) Register here Speaker’s Bio Dr. Wim Trypsteen is a postdoctoral researcher at Ghent University and [...]
Ghent, Belgium & Villejuif, France, May 2, 2019 Renowned Digital PCR experts at Ghent University join hands with Stilla Technologies To expand the frontiers of Crystal™ dPCR using the Naica™ System Ghent University, one of the leading research institutes working on digital PCR (dPCR) technology, recently signed a collaborative agreement with Stilla [...]
June the 19th 2019, Digital PCR Course with the Naica System Stilla technologies in collaboration with TATAA Biocenter offers you the opportunity to test your samples at this workshop*! From 9:30 am to 6:00 pm in Gothenburg (Sweden) Register here Agenda 9.30 am: Course registration 10.00 am: "The unique strengths and advantages of Digital [...]
May the 22nd 2019, A Digital PCR Liquid Biopsy Workflow for Mutation Detection and Therapeutic Monitoring by Dr. Daniel Daniel Henaff (Id-Solutions) & Caroline Charky (Stilla Technologies) Speaker’s Bio Daniel Henaff is the R&D Manager at ID-Solutions. After completing his PhD in 2010 at the Institute of Molecular Genetics of Montpellier, he [...]
Stilla Technologies Launches High-Throughput Digital PCR Chip November 2018, Article on Genomeweb Get the PDF file Stilla Technologies Launches High-Throughput Digital PCR Chip, Plans Six-Color System NEW YORK (GenomeWeb) – As digital PCR gains widespread acceptance as a workhorse research tool and begins pushing into the clinical market, French company Stilla Technologies [...]
Stilla Technologies Won the SLAS New Product Award 2019 Stilla Technologies was rewarded with the SLAS (The Society for Laboratory Automation and Screening) 2019 New Product Award for the Naica HT & the Opal chip, out of a list of more than 60 companies! Rémi Dangla (CEO), Etienne Fradet (VP of R&D), [...]
Illumina Ventures Leads €16M Series A Investment in Digital PCR Firm Stilla Technologies November 2018, Article on Genomeweb.com Get the PDF file Stilla Technologies announced today that it has completed a €16 million ($18.3 million) Series A financing round led by Illumina Ventures. Kurma Partners, LBO France, BNP Paribas Développement, Paris Saclay [...]
Paris-based Stilla Technologies has raised €16M in a Series A round November 2018, Article on Labiotech.eu Get the PDF file Paris-based Stilla Technologies has raised €16M in a Series A round to sell and develop a high-precision PCR system for DNA quantification with promising applications in diagnostics. The round was led by [...]
November 20th, 2018 Stilla Technologies completes €16 Million Series A Illumina Ventures led the financing round Objective: financing to commercialize its novel digital PCR system and develop clinical applications. Paris, November 20th, 2018. Stilla Technologies, the European provider of pioneering digital PCR solutions for high precision genetic analysis, announced today the successful completion [...]
September the 25th 2018, Implementation of Digital PCR in a Diagnostic Lab: Evaluation of Minimal Residual Disease by Dr Benjamin Tournier, University Hospital of Dijon 8 AM PDT | 11 AM EDT | 4PM BST | 5PM CEST Speaker’s Bio After completing a molecular biology thesis about genetic and epigenetic alterations in [...]
